Coloplast A/S (CLPBF) Projected to Post Quarterly Earnings on Tuesday

Coloplast A/S (OTCMKTS:CLPBF) is projected to issue its resultson Tuesday, May 12th. Analysts expect the company to announce earnings of $0.9020 per share and revenue of $1.0903 billion for the quarter.

Coloplast A/S Price Performance

CLPBF stock remained flat at $63.59 during trading on Tuesday. 1,304 shares of the company’s stock were exchanged, compared to its average volume of 1,272. Coloplast A/S has a 52-week low of $60.75 and a 52-week high of $106.25. The company has a fifty day moving average of $68.92 and a two-hundred day moving average of $80.72.

About Coloplast A/S

Coloplast A/S is a Denmark‐based medical device company specializing in the development and manufacturing of products and services for people with intimate healthcare needs. Founded in 1957 by Aage Louis‐Hansen and Poul Mollgaard Jensen, the company set out to improve quality of life for patients requiring ostomy care, and has since expanded into multiple clinical areas. Coloplast is headquartered in Humlebæk, Denmark, and combines in‐house research and development with strategic partnerships to drive innovation in its core markets.

The company’s product portfolio is organized around four primary areas: ostomy care, continence care, wound and skin care, and interventional urology.